ArticleMolecular cancer therapeutics2024

Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9.6.

Eric N Aguilar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.